AC
Acarix AB (publ)
ACIXF · OTC
$0.02 +0.00% (+$0.00)
Market Cap 213.1M kr
P/E Ratio -
Div. Yield -
ROE 100.11%
Bulios Fair Price
$0.02
0.5% upside
Current Price
$0.02
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ACIXF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
20 /100
Expensive P/B 4.91x
P/S 23.19x
EV/EBITDA N/A
Growth
46 /100
Stable Book val. growth 9.77%
Rev. growth 8.04%
FCF growth N/A
Profitability
20 /100
Weak Net margin 427.01%
Op. margin 421.83%
FCF margin 252.35%
Quality
2 /100
Poor ROE 100.11%
ROA 82.91%
Asset turnover 0.19x
Debt
69 /100
Low Current ratio 10.67x
Int. coverage -23.35x
Debt/Equity 0.00x
Stability
71 /100
Stable Rev. volatility 9.56%
EPS volatility 3.71%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ACIXF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Aamir Mahmood
Employees
8
Headquarters
Malmö
Upcoming events
05 NOV
Earnings
Upcoming earnings report